Hologram Sciences, the consumer-facing company launched by Royal DSM, has released its first direct-to-consumer brand called d.velop.
Hologram Sciences (New York City, NY), the consumer-facing company launched by Royal DSM, has released its first direct-to-consumer brand called d.velop. The new brand offers an exclusive form of vitamin D the firm says was scientifically shown1 to help achieve optimal levels three times faster than conventional vitamin D supplements. In addition to the supplement, the brand also offers a diagnostic kit to test one’s vitamin D levels prior to and two weeks after supplementation, as well as digital support.
“At Hologram, we’re committed to creating and rapidly scaling products that are backed by proven science, pioneering technology, and habit-building,” said Ian Brady, CEO Hologram Sciences, in a press release. “We chose to focus our first brand and product on immunity because we wanted to give people a tool to feel more confident about their health as they step back into the world.”
Consumers shopping d.velop will have a choice of purchasing a single 30-day supply or a three-month supply of the d.velop vitamin D. Access to the free d.velop app will provide users with actionable information to help them understand their immune health more precisely, and then take action. The app will also include access to live coaching from registered dietitians who can answer questions and provide tips for staying on course. The subscription option will provide consumers with the free two-pack vitamin D test, so that they can test their levels before and after taking the supplement.
“No two people are the same and that goes for nutrition as well,” said Melissa Rifkin, MS, RD, CDN, in a press release. “Understanding how to increase one’s immunity is one of the biggest challenges people face and d.velop addresses that challenge in a very personal way. I’m excited to partner with Hologram to share the importance of personalized nutrition and holistic health.”
Reference
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.